UNCY

News Unicycive Posts 65% EPS Gain in Q2

14d ago

News Unicycive Therapeutics GAAP EPS of -$0.54 misses by $0.08

21d ago

SEC filing UNCY Reports $57.1M Cash, $1.6M R&D Expenses, $(0.54) EPS, OLC NDA Review On Track

21d ago

News Crown Castle outlines $65M cost reduction and targets $7B debt repayment as tower focus intensifies

117d ago

News Unicycive granted FDA review for resubmitted marketing application for kidney disease drug

124d ago

News UNICYCIVE LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Unicycive to Contact the Firm Regarding Filed Class Action Lawsuit Before October 14th

153d ago

News ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – UNCY

153d ago

News UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

153d ago

News UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive

153d ago

News ROSEN, REGARDED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important October 14 Deadline in Securities Fraud Lawsuit – UNCY

153d ago

News Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics (UNCY) and KinderCare Learning Companies, Inc. (KLC)

153d ago

News UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

153d ago

News ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important October 14 Deadline in Securities Fraud Lawsuit – UNCY

153d ago